We were delighted to speak to Anthony Sebba (Arthritis Associates, FL, USA) to discuss whether pain and inflammation are independent of each other in patients with rheumatoid arthritis. The abstract ‘Pain and Other Patient-Reported Outcomes in Patients with Rheumatoid Arthritis Who Did or Did Not Achieve Treatment Response Based on Improvement in Swollen Joints in Tocilizumab Clinical Trials.’ (ABSTRACT NUMBER: 1237) was presented at the virtual ACR Convergence 2020, 5-9 November 2020.
Questions
- What have we learned about the pathophysiological processes underlying pain in patients with rheumatoid arthritis (RA)? (0:35)
- What was the rationale for your study analysing pain and other patient-reported outcomes? (4:51)
Disclosures: Consultant or speaker for Genentech, Sanofi, Lilly, Gilead and Amgen.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ACR 2020 Annual Meeting (Virtual).
